Prognostic and clinical significance for the combination of systemic inflammation response index and platelet--lymphocyte ratio in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer

Xin Yin(Harbin Medical University), Yingwei Xue(Harbin Medical University), Yan Ma(Harbin Medical University), Yimin Wang(Harbin Medical University), Xiliang Cong(Harbin Medical University), Xuan Lin(Beijing Technology and Business University), Chunfeng Li(Harbin Medical University), Tianyi Fang(Harbin Medical University)
Unknown
July 7, 2020
10.22541/au.159411425.59706215
Cited by 0

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients
|Scientific Reports|2021|143
Dietary fiber intake and risk of metabolic syndrome: A meta-analysis of observational studies
|Clinical Nutrition|2017|115